The estimated Net Worth of David P Meeker is at least 20.5 百万$ dollars as of 27 August 2024. Dr Meeker owns over 4,555 units of Rhythm Pharmaceuticals stock worth over 17,605,840$ and over the last 8 years he sold RYTM stock worth over 1,784,275$. In addition, he makes 1,089,318$ as Chairman、 Pres & CEO at Rhythm Pharmaceuticals.
Dr has made over 7 trades of the Rhythm Pharmaceuticals stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 4,555 units of RYTM stock worth 6,514$ on 27 August 2024.
The largest trade he's ever made was selling 45,494 units of Rhythm Pharmaceuticals stock on 19 March 2024 worth over 1,784,275$. On average, Dr trades about 4,175 units every 93 days since 2017. As of 27 August 2024 he still owns at least 357,044 units of Rhythm Pharmaceuticals stock.
You can see the complete history of Dr Meeker stock trades at the bottom of the page.
Dr. David P. Meeker M.D. is the Chairman, Pres & CEO at Rhythm Pharmaceuticals.
As the Chairman、 Pres & CEO of Rhythm Pharmaceuticals, the total compensation of Dr D at Rhythm Pharmaceuticals is 1,089,318$. There are 1 executives at Rhythm Pharmaceuticals getting paid more, with Hunter Smith having the highest compensation of 1,922,850$.
Dr D is 67, he's been the Chairman、 Pres & CEO of Rhythm Pharmaceuticals since . There are no older and 18 younger executives at Rhythm Pharmaceuticals.
David's mailing address filed with the SEC is C/O TREVI THERAPEUTICS, INC., 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510.
Over the last 13 years, insiders at Rhythm Pharmaceuticals have traded over 83,445,563$ worth of Rhythm Pharmaceuticals stock and bought 6,290,000 units worth 106,961,700$ . The most active insiders traders include Forest Baskett、Scott D Sandell、Peter J Barris. On average, Rhythm Pharmaceuticals executives and independent directors trade stock every 17 days with the average trade being worth of 3,358,405$. The most recent stock trade was executed by Pamela J. Cramer on 9 September 2024, trading 4,099 units of RYTM stock currently worth 77,963$.
rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.
Rhythm Pharmaceuticals executives and other stock owners filed with the SEC include: